| 1 | — (10.1186/1477-9560-4-15) | Abstract References ORCID License | 228.78 | 193 |
| 2 | Relationship between ABO blood group and von Willebrand fact… (10.1186/1477-9560-5-14) | Abstract References ORCID License | 217.32 | 148 |
| 3 | Laboratory assessment of rivaroxaban: a review (10.1186/1477-9560-11-11) | Abstract References ORCID License | 214.30 | 138 |
| 4 | — (10.1186/1477-9560-5-3) | Abstract References ORCID License | 201.70 | 103 |
| 5 | Oral rivaroxaban versus standard therapy for the treatment o… (10.1186/1477-9560-11-21) | Abstract ORCID License | 199.56 | 457 |
| 6 | — (10.1186/1477-9560-2-12) | Abstract References ORCID License | 193.95 | 86 |
| 7 | The incidence of venous thromboembolism and practice of deep… (10.1186/1477-9560-9-1) | Abstract References ORCID License | 193.45 | 85 |
| 8 | Hemostasis and inflammation: two of a kind? (10.1186/1477-9560-7-15) | Abstract References ORCID License | 178.53 | 60 |
| 9 | — (10.1186/1477-9560-4-6) | Abstract References ORCID License | 177.09 | 58 |
| 10 | — (10.1186/1477-9560-4-4) | Abstract References ORCID License | 174.04 | 54 |
| 11 | — (10.1186/1477-9560-2-9) | Abstract References ORCID License | 169.90 | 49 |
| 12 | Platelets and platelet adhesion molecules: novel mechanisms… (10.1186/s12959-016-0100-6) | Abstract ORCID License | 165.91 | 162 |
| 13 | Comparison of VerifyNow-P2Y12 test and Flow Cytometry for mo… (10.1186/1477-9560-7-4) | Abstract References ORCID License | 162.32 | 41 |
| 14 | Influenza infection and risk of acute pulmonary embolism (10.1186/1477-9560-5-16) | Abstract References ORCID License | 161.28 | 40 |
| 15 | Rivaroxaban and other novel oral anticoagulants: pharmacokin… (10.1186/1477-9560-11-10) | Abstract ORCID License | 160.25 | 136 |
| 16 | — (10.1186/1477-9560-3-1) | Abstract References ORCID License | 155.63 | 35 |
| 17 | Risk factors for perioperative venous thromboembolism: A ret… (10.1186/1477-9560-8-17) | Abstract References ORCID License | 153.15 | 33 |
| 18 | Perioperative management of patients on direct oral anticoag… (10.1186/s12959-017-0137-1) | Abstract ORCID License | 151.28 | 103 |
| 19 | Quality of vitamin K antagonist control and outcomes in atri… (10.1186/1477-9560-12-14) | Abstract ORCID License | 147.28 | 91 |
| 20 | The antithrombotic profile of aspirin. Aspirin resistance, o… (10.1186/1477-9560-2-1) | Abstract ORCID License | 146.93 | 90 |
| 21 | — (10.1186/1477-9560-2-8) | Abstract References ORCID License | 146.24 | 28 |
| 22 | Venous thromboembolism in the elderly: efficacy and safety o… (10.1186/1477-9560-12-21) | Abstract ORCID License | 143.54 | 81 |
| 23 | The diagnosis and treatment of venous thromboembolism in Asi… (10.1186/s12959-017-0155-z) | Abstract ORCID License | 143.54 | 81 |
| 24 | Validation of a modified thromboelastometry approach to dete… (10.1186/s12959-016-0076-2) | Abstract ORCID License | 143.14 | 80 |
| 25 | Combining Taipan snake venom time/Ecarin time screening with… (10.1186/1477-9560-5-12) | Abstract References ORCID License | 141.50 | 25 |
| 26 | Clinical factors influencing normalization of prothrombin ti… (10.1186/1477-9560-6-15) | Abstract References ORCID License | 141.50 | 25 |
| 27 | — (10.1186/1477-9560-4-11) | Abstract References ORCID License | 139.79 | 24 |
| 28 | — (10.1186/1477-9560-2-11) | Abstract References ORCID License | 138.02 | 23 |
| 29 | DOACs – advances and limitations in real world (10.1186/s12959-016-0111-3) | Abstract ORCID License | 136.47 | 65 |
| 30 | Derivation of the non-inferiority margin for the evaluation… (10.1186/1477-9560-11-13) | Abstract References ORCID License | 136.17 | 22 |
| 31 | An unusual case of peripartum cardiomyopathy manifesting wit… (10.1186/1477-9560-5-18) | Abstract References ORCID License | 136.17 | 22 |
| 32 | Clopidogrel in Orthopaedic patients: a review of current pra… (10.1186/1477-9560-5-6) | Abstract References ORCID License | 136.17 | 22 |
| 33 | Ischemic stroke risk, smoking, and the genetics of inflammat… (10.1186/1477-9560-6-11) | Abstract References ORCID License | 136.17 | 22 |
| 34 | Application of basic and composite thrombelastography parame… (10.1186/1477-9560-7-14) | Abstract References ORCID License | 136.17 | 22 |
| 35 | Platelet function in brown bear (Ursus arctos) compared to m… (10.1186/1477-9560-8-11) | Abstract References ORCID License | 134.24 | 21 |
| 36 | Causes of venous thrombosis (10.1186/s12959-016-0108-y) | Abstract ORCID License | 132.81 | 58 |
| 37 | Rivaroxaban versus enoxaparin/vitamin K antagonist therapy i… (10.1186/1477-9560-12-25) | Abstract ORCID License | 132.26 | 57 |
| 38 | — (10.1186/1477-9560-4-13) | Abstract References ORCID License | 132.22 | 20 |
| 39 | Gender differences of polymorphisms in the TF and TFPI genes… (10.1186/1477-9560-8-7) | Abstract References ORCID License | 132.22 | 20 |
| 40 | Risk factors in coronary atherosclerosis athero-inflammation… (10.1186/1477-9560-1-4) | Abstract ORCID License | 131.69 | 56 |
| 41 | Vitamin K antagonist use: evidence of the difficulty of achi… (10.1186/s12959-016-0088-y) | Abstract ORCID License | 131.11 | 55 |
| 42 | TEG® and RapidTEG® are unreliable for detecting warfarin-coa… (10.1186/1477-9560-12-4) | Abstract ORCID License | 130.53 | 54 |
| 43 | The approval of revised diagnostic criteria for DIC from the… (10.1186/s12959-017-0142-4) | Abstract ORCID License | 129.93 | 53 |
| 44 | Resolution of left atrial appendage thrombus with apixaban (10.1186/1477-9560-11-26) | Abstract ORCID License | 129.32 | 52 |
| 45 | New oral anticoagulants: discussion on monitoring and adhere… (10.1186/1477-9560-11-8) | Abstract ORCID License | 129.32 | 52 |
| 46 | The risk of venous thromboembolism associated with periphera… (10.1186/s12959-017-0148-y) | Abstract ORCID License | 128.70 | 51 |
| 47 | Drug-drug interactions and risk of bleeding among inpatients… (10.1186/1477-9560-12-20) | Abstract ORCID License | 126.76 | 48 |
| 48 | Point-of-Care Testing of Hemostasis in Cardiac Surgery (10.1186/1477-9560-1-1) | Abstract ORCID License | 126.09 | 47 |
| 49 | — (10.1186/1477-9560-4-12) | Abstract References ORCID License | 125.53 | 17 |
| 50 | — (10.1186/1477-9560-4-5) | Abstract References ORCID License | 125.53 | 17 |